Symbols

SNTI

Senti Biosciences·NASDAQ

--(--)

SNTI Profile

Senti Biosciences, Inc.

A biotech company that innovating cell and gene therapies using its proprietary gene circuit platform

Industry

Biological Technology

Established Date

03/01/2021

Listing Date

05/26/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.sentibio.com

Security Type

Common stock

Office address

2 Corporate Drive First Floor South San Francisco CA 94080

Business

Introduction

Senti Biosciences, Inc., was incorporated in Delaware on March 1, 2021. The company is a clinical-stage biotechnology company that leverages its gene circuit platform technology to develop next-generation cell and gene therapies for patients with incurable diseases. The company's mission is to create a new generation of smarter medicines that use novel and unprecedented methods to defeat complex diseases.